LEADER 03695nam 22006013u 450 001 9910462770203321 005 20210117152135.0 010 $a1-898683-90-5 035 $a(CKB)2670000000346243 035 $a(EBL)2055843 035 $a(MiAaPQ)EBC2055843 035 $a(MiAaPQ)EBC3329153 035 $a(Au-PeEL)EBL2055843 035 $a(OCoLC)910446926 035 $a(EXLCZ)992670000000346243 100 $a20150601d2009|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Identification and Treatment of Gait Problems in Cerebral Palsy , 2nd Edition$b[electronic resource] 205 $a2nd ed. 210 $aLondon $cMac Keith Press$d2009 215 $a1 online resource (1240 p.) 225 1 $aClinics in Developmental Medicine 300 $aDescription based upon print version of record. 311 $a1-898683-65-4 327 $aCover; Title; Copyright; Contents; AUTHORS' APPOINTMENTS; PREFACE; SECTION 1: TYPICAL MUSCULOSKELETAL DEVELOPMENT; PART I: GAIT PROBLEMS IN CEREBRAL PALSY; 1.1. THE NEURAL CONTROL OF MOVEMENT; 1.2. MUSCULOSKELETAL GROWTH AND DEVELOPMENT; 1.3. NORMAL GAIT; SECTION 2: GAIT PATHOLOGY IN INDIVIDUALS WITH CEREBRAL PALSY INTRODUCTION AND OVERVIEW; 2.1. MECHANISMS AND MANIFESTATIONS OF NEONATAL BRAIN INJURY; 2.2. THE PATHOPHYSIOLOGY OF SPASTICITY; 2.3. BASAL GANGLIA INJURY AND RESULTING MOVEMENT DISORDERS; 2.4. CONSEQUENCES OF BRAIN INJURY ON MUSCULOSKELETAL DEVELOPMENT 327 $a2.5. MUSCLE STRUCTURE AND FUNCTION IN CEREBRAL PALSY2.6. CLASSIFICATION OF CEREBRAL PALSY AND PATTERNS OF GAIT PATHOLOGY; 2.7. THE NATURAL HISTORY OF AMBULATION IN CEREBRAL PALSY; SECTION 3: PATIENT ASSESSMENT INTRODUCTION AND OVERVIEW; 3.1. CLINICAL ASSESSMENT; 3.2. FOOT BIOMECHANICS AND PATHOLOGY; 3.3. NEUROIMAGING OF THE BRAIN; 3.4. RADIOGRAPHIC EVALUATION OF THE PATIENT WITH CEREBRAL PALSY; 3.5. GAIT ANALYSIS: KINEMATICS, KINETICS, ELECTROMYOGRAPHY,OXYGEN CONSUMPTION AND PEDOBAROGRAPHY; 3.6. MODELING AND SIMULATION OF NORMAL AND PATHOLOGICAL GAIT 327 $aINTERLUDE: INTRODUCTION AND OVERVIEW OF TREATMENT PHILOSOPHYSECTION 4: NON-OPERATIVE TREATMENT; PART II: TREATMENT; 4.1. PHYSICAL THERAPY; 4.2. ORTHOSES; 4.3. PHARMACOLOGIC TREATMENT WITH ORAL MEDICATIONS; 4.4. PHARMACOLOGIC TREATMENT WITH BOTULINUM TOXIN; SECTION 5: OPERATIVE TREATMENT; 5.1. TREATMENT OF SPASTICITY WITH INTRATHECAL BACLOFEN; 5.2. TREATMENT OF SPASTICITY WITH SELECTIVE DORSAL RHIZOTOMY; 5.3. NEUROSURGICAL TREATMENT OF DYSTONIA; 5.4. REHABILITATION FOLLOWING SPASTICITY REDUCTION; 5.5. ORTHOPAEDIC TREATMENT OF MUSCLE CONTRACTURES 330 $a The only book dealing with the treatment of gait problems in cerebral palsy. From neurological control, musculoskeletal growth and cerebral injury through to treatment strategies (inclding orthopedic surgery). 410 0$aClinics in Developmental Medicine 606 $aCerebral palsy -- Complications 606 $aChild 606 $aGait disorders, Neurologic -- Therapy 606 $aGait disorders 608 $aElectronic books. 615 4$aCerebral palsy -- Complications. 615 4$aChild. 615 4$aGait disorders, Neurologic -- Therapy. 615 4$aGait disorders. 676 $a618.92836 700 $aGage$b James R$01050607 701 $aSchwartz$b Michael H$098584 701 $aKoop$b Steven E$01050608 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910462770203321 996 $aThe Identification and Treatment of Gait Problems in Cerebral Palsy, 2nd Edition$92480519 997 $aUNINA